Overexpression of BCL2L12-T33A significantly enhanced tumor formation, as indicated by increased tumor volume and weight, whereas cells overexpressing BCL2L12-T33E showed a weaker tumor formation ability, although still greater than that of the control group (Figure 6K-M). The gene discussed is BCL2L12; the disease is neoplasm.